Brello Health tirzepatide programs pair telehealth visits with compounded or brand-name GLP-1 medication. Learn how pricing, dosing, and safety work.
Brello Health is a US telehealth subscription service that connects patients with licensed clinicians who can evaluate them for tirzepatide, the dual GLP-1/GIP medication also sold as Zepbound and Mounjaro. If a provider approves treatment, the medication ships to your door as part of a flat monthly fee rather than a per-visit billing model. The compounded version dispensed through telehealth platforms is not FDA-approved, and its availability has shifted repeatedly since the FDA resolved the branded drug shortage.
What the Brello Health Tirzepatide Program Includes
Brello Health runs on the same direct-to-consumer model as most online weight-loss clinics: an online intake form, a clinician review, and medication shipped by a licensed pharmacy. Nothing about that process requires an in-person office visit in most states.
- Online intake: a questionnaire covering your weight, medical history, and current prescriptions.
- Clinician review: a state-licensed provider decides whether tirzepatide is appropriate and writes the prescription if it is.
- Pharmacy fulfillment: a licensed compounding pharmacy prepares the vial and ships it, usually within a few business days.
- One monthly subscription: the visit, the drug, and the shipping are bundled into a single recurring charge.
- Ongoing follow-up: messaging or video check-ins for dose adjustments and side-effect management.
Most people searching for brello tirzepatide want three answers: what the monthly fee actually covers, whether the vial is compounded or brand-name, and how quickly refills arrive. Get all three in writing before you enter a card number.
Brello Health Tirzepatide Cost: What to Expect to Pay
Prices at US telehealth weight-loss companies change every few months, so treat any published number as a starting point and confirm the current rate directly with the company.
| Cost item | Typical range across US telehealth GLP-1 programs | What to confirm with Brello |
|---|---|---|
| Monthly compounded tirzepatide subscription | About $150 to $400 | Does the fee include the vial, syringes, alcohol pads, and clinician messages? |
| Initial consultation or lab work | $0 to $99 | Is bloodwork required, and who pays for it? |
| Brand-name Zepbound or Mounjaro with insurance | $0 to $1,000+ per month | Does the company handle prior authorization paperwork? |
| Brand-name self-pay vials | Roughly $349 to $499 per month | Would a manufacturer savings card beat the subscription price? |
Flat-rate pricing is common, which means the monthly charge usually stays the same whether you are on 2.5 mg or 15 mg. Ask how the subscription renews, how to cancel, and what happens if a refill is delayed or arrives damaged.
Compounded vs. Brand-Name Tirzepatide
Tirzepatide is the active ingredient in both versions. What differs is who makes it and how tightly it is regulated.
| Feature | Compounded tirzepatide | Brand-name Zepbound / Mounjaro |
|---|---|---|
| FDA approval | Not FDA-approved as a drug | FDA-approved |
| Manufacturer | State-licensed compounding pharmacy | Eli Lilly |
| Dosing | Often measured in "units" on a syringe | Fixed-strength pens or vials in milligrams |
| Typical monthly cost | Lower | Higher without insurance |
| Insurance coverage | Rarely covered | Sometimes covered for weight management or diabetes |
| Supply rules | Restricted when the branded drug is not in shortage | Available through normal channels |
Compounded tirzepatide is not FDA-approved for human use in the United States, and the FDA has stated that compounded copies should no longer be produced now that the branded shortage is resolved. Court challenges have allowed some pharmacies to keep dispensing it during litigation, so whether you can still order it depends on the date and your state.
Eligibility, Dosing, and Realistic Results
Prescribing criteria generally follow the FDA labels: a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, high cholesterol, or type 2 diabetes. A clinician can decline to prescribe for other reasons, including pregnancy or a history of pancreatitis.
How the dose is built up
- Weeks 1 to 4: 2.5 mg once weekly, a starter dose not intended for weight loss on its own.
- Weeks 5 to 8: 5 mg weekly if the starter dose is tolerated.
- Ongoing: increases of 2.5 mg roughly every four weeks, up to a maximum of 15 mg weekly.
In the SURMOUNT-1 trial, adults taking 15 mg of tirzepatide weekly lost an average of about 20% of their body weight over 72 weeks. Individual results vary widely, and much of the weight typically returns if the medication is stopped without lasting changes to diet and activity.
Side Effects and Safety Questions to Ask Before You Start
The most common side effects are gastrointestinal: nausea, vomiting, diarrhea, constipation, and burping. They often ease as the body adjusts, and slower dose increases tend to reduce them.
Less common but more serious risks include pancreatitis, gallbladder disease, and gastroparesis. Tirzepatide is not recommended for people with a personal or family history of medullary thyroid cancer or MEN2, and it is not for use during pregnancy.
Anyone taking insulin or a sulfonylurea needs dose adjustments and closer monitoring, because combining those drugs with tirzepatide can cause low blood sugar. Speak with a licensed healthcare professional before starting, stopping, or stacking tirzepatide with any other injectable.
How Tirzepatide Compares With Other Weight-Loss Drugs
Tirzepatide is one option among several, and many people research cagrilintide vs tirzepatide before choosing a program. Cagrilintide targets amylin rather than GLP-1 or GIP, and it is still investigational in the United States.
| Drug | Mechanism | US regulatory status | Form |
|---|---|---|---|
| Tirzepatide (Zepbound, Mounjaro) | GLP-1 + GIP | FDA-approved | Weekly injection |
| Semaglutide (Wegovy, Ozempic) | GLP-1 | FDA-approved | Weekly injection; daily oral |
| Cagrilintide | Amylin analog | Investigational | Weekly injection in trials |
| Retatrutide | GLP-1 + GIP + glucagon | Investigational | Weekly injection in trials |
A comparison of cagrilintide vs retatrutide vs tirzepatide really compares one approved drug with two experimental ones, so only tirzepatide can be prescribed outside a clinical trial today. Any clinic selling cagrilintide or retatrutide as a ready-to-ship product is selling something unapproved.
Add-Ons People Ask About: AOD 9604 and Lipo-C
Some telehealth menus also list AOD 9604, a synthetic fragment of human growth hormone, and Lipo-C, an injectable blend of B vitamins and amino acids marketed for fat loss. Neither is FDA-approved for weight loss.
There is no published human trial data on combining AOD 9604 with tirzepatide, so stacking them adds cost and injection burden without proven benefit. If you are considering aod 9604 with tirzepatide, ask the prescriber what evidence supports the combination and what monitoring is planned.
The same caution applies to lipo-c and tirzepatide. Lipo-C is sometimes pitched as a weekly energy or fat-burning shot alongside a GLP-1, but the B12 in it mainly helps people with a diagnosed deficiency, and the methionine and inositol components have little human data behind them for weight loss.
Bottom Line on Brello Health Tirzepatide
Brello Health offers a subscription-style path to tirzepatide with online intake, clinician review, and home delivery. The trade-off is that compounded tirzepatide is not FDA-approved, its legal status is unsettled, and the price you see today may not hold next quarter.
Compare the total monthly cost against brand-name Zepbound with insurance or a savings card, read the cancellation terms, and talk to a licensed healthcare professional about whether tirzepatide fits your health history.
Frequently Asked Questions
Is Brello Health tirzepatide legit?
Brello Health is a legitimate US telehealth company that uses state-licensed clinicians and licensed pharmacies, which is different from the compounded medication itself being FDA-approved. Compounded tirzepatide is not an FDA-approved drug, and the FDA has said compounded copies should stop now that the branded shortage is resolved. Before ordering, ask which pharmacy fills the prescription and verify that pharmacy's state license.
How much does Brello Health charge for tirzepatide?
Most US telehealth GLP-1 subscriptions run about $150 to $400 per month for compounded tirzepatide, with brand-name versions costing more. Pricing changes often, so confirm the current monthly rate, what it includes, and the cancellation policy directly with the company before you subscribe.
Is compounded tirzepatide still available in the United States?
Availability is limited and has changed repeatedly since the FDA declared the tirzepatide shortage resolved. Federal regulators have directed compounding pharmacies to stop making copies of the drug, while ongoing litigation has allowed some pharmacies to continue dispensing it for now. State rules also vary, so check the current status in your state.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.